Levodopa Benserazide Teva

Levodopa, the active ingredient in Levodopa Benserazide Teva, is an antiparkinson agent presented as an oral tablet for oral use. It is combined with benserazide to treat Parkinson's disease and related Parkinsonian syndromes by restoring central dopamine levels.

GNH USA supplies Levodopa Benserazide Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Levodopa/benserazide is used in the management of disorders that involve dopamine deficiency within the central nervous system. - Parkinson's disease: improves motor symptoms by increasing cerebral dopamine. - Parkinsonian syndrome: alleviates rigidity, bradykinesia and tremor. - Secondary Parkinsonism (e.g., drug‑induced): restores dopaminergic activity when the condition is reversible.

Levodopa/benserazide may cause a range of adverse reactions, some of which are more frequent than others.

Common Side Effects: - Nausea: gastrointestinal upset occurring early in therapy. - Orthostatic hypotension: dizziness upon standing due to vasodilation. - Headache: mild to moderate intensity. - Insomnia: difficulty initiating or maintaining sleep. - Dyskinesia: involuntary movements, especially at higher doses. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe hypotension: marked blood‑pressure drop requiring medical attention. - Psychosis or hallucinations: especially in elderly patients. - Cardiac arrhythmias: rare but potentially life‑threatening. - Neuroleptic malignant‑like syndrome: high fever, rigidity, autonomic instability. - Severe allergic reaction: rash, swelling, or anaphylaxis.

When prescribing levodopa/benserazide, clinicians should consider several safety measures. - Monitor blood pressure: watch for orthostatic changes, especially after dose initiation. - Assess psychiatric status: be alert for hallucinations, confusion, or mood swings. - Adjust dose in renal impairment: reduced clearance may increase plasma levels. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal symptoms. - Use with caution in the elderly: increased sensitivity to side effects. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levodopa/benserazide can interact with a variety of medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Pyridoxine (vitamin B6) at high doses: enhances peripheral decarboxylation, reducing central effect. - Anticholinergics: may diminish therapeutic benefit.

Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: potential for serotonin syndrome. - Antihypertensive agents: additive hypotensive effect. - Iron or calcium supplements: decrease levodopa absorption; separate dosing by at least 2 hours.